BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 6305366)

  • 21. Effect of the purified phospholipases A2 from snake and bee venoms on rabbit platelet function.
    Ouyang C; Huang TF
    Toxicon; 1984; 22(5):705-18. PubMed ID: 6441310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of inhibitory effect of cyclic GMP on arachidonic acid- or collagen-induced aggregation in rabbit platelets.
    Matsuoka I; Nakanishi H
    Thromb Res; 1985 Jan; 37(1):185-93. PubMed ID: 2984801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that KF4939, a new anti-platelet agent, inhibits phospholipase activation in rabbit platelets: different aspects from cyclic AMP increasing agents and calmodulin antagonist.
    Yamada K; Shuto K; Kubo K; Nakamizo N
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):141-54. PubMed ID: 6329114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the mechanism of the inhibition of platelet aggregation and release induced by high levels of arachidonate.
    Linder BL; Goodman DS
    Blood; 1982 Aug; 60(2):436-45. PubMed ID: 6284285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of phorbol 12-myristate 13-acetate on collagen-induced signal transduction in rabbit platelet.
    Sato T; Akiba S; Fujii T
    Thromb Res; 1988 Mar; 49(6):567-79. PubMed ID: 3133818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
    Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M
    Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet effect of demethyldiisoeugenol.
    Liao CH; Ko FN; Kuo YH; Teng CM
    Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid.
    Aharony D; Smith JB; Silver MJ
    Biochim Biophys Acta; 1982 Oct; 718(2):193-200. PubMed ID: 6814496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of trimetazidine dihydrochloride on aggregation, serotonin release and malondialdehyde production in rabbit platelets.
    Shirahase H; Suzuki Y; Osumi S; Kakeya N; Kurahashi K
    Jpn J Pharmacol; 1988 May; 47(1):29-34. PubMed ID: 3137386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cryptolepine on collagen-induced aggregation and on the mobilization and metabolism of arachidonic acid by rabbit platelets.
    Oyekan AO; Ablordeppey SY
    Gen Pharmacol; 1993 Sep; 24(5):1285-90. PubMed ID: 8270188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory mechanisms of dantrolene on platelet aggregation.
    Chou TC; Li CY
    Thromb Res; 1999 Nov; 96(4):299-307. PubMed ID: 10593433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome.
    Yoshida N; Aoki N
    Blood; 1978 Nov; 52(5):969-77. PubMed ID: 698401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets.
    Srivastava KC; Malhotra N
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):73-81. PubMed ID: 2011614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.